{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:55:58Z","timestamp":1787846158831,"version":"build-2784847793"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":3077,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004351","name":"Cisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004351","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Izzy fund for Immunologic Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Relapses of immune-mediated hemolytic anemia (IMHA), thrombocytopenia (ITP), or polyarthropathy (IMPA) occur despite normal hematologic and cytologic parameters. Thymidine kinase 1 (TK1), canine C-reactive protein (c-CRP), haptoglobin (HPT), and 25-Hydroxyvitamin-D (25(OH)D) might be adjunct to current monitoring strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis\/Objectives<\/jats:title>\n                    <jats:p>Compare serum concentrations of TK1, c-CRP, HPT, and 25(OH)D in dogs with well- and poorly controlled primary IMHA, ITP, or IMPA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Thirty-eight client-owned dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective descriptive study. Dogs diagnosed with IMHA, ITP, or IMPA had serum biomarker concentrations measured commercially. Disease control was assessed by hematocrit\/PCV and reticulocyte count, platelet count, and synovial fluid cytology for IMHA, ITP, and IMPA, respectively. Statistical analysis performed by Mann-Whitney rank-sum tests and receiver operating characteristic curves.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TK1 and c-CRP, but not HPT significantly decreased with well- versus poorly controlled IMHA (P = 0.047, P = 0.028, P = 0.37). C-CRP, but not TK or HPT was significantly lower with well- versus poorly controlled IMPA (P = 0.05, P = 0.28, P = 0.84). Sensitivity and specificity of TK and c-CRP (simultaneously) for detecting dogs with poorly controlled IMHA were 88 and 100%, respectively. Sensitivity and specificity of c-CRP for detecting poorly controlled dogs with IMPA were 13 and 100%, respectively. 92% of dogs were vitamin D insufficient (&amp;lt;100 ng\/mL) regardless of disease control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Combining TK1 and c-CRP might act markers of disease control in dogs with IMHA. Canine-CRP cannot be recommended as an independent marker of disease control in IMPA. 25(OH)D insufficiency in immune-mediated disorders might benefit from further study to determine if supplementation could improve therapeutic response or reduce disease risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.14787","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T02:08:55Z","timestamp":1502676535000},"page":"1430-1440","source":"Crossref","is-referenced-by-count":24,"title":["Serum Thymidine Kinase 1, Canine-C-Reactive Protein, Haptoglobin, and Vitamin D Concentrations in Dogs with Immune-Mediated Hemolytic Anemia, Thrombocytopenia, and Polyarthropathy"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7695-5562","authenticated-orcid":false,"given":"M.","family":"Grobman","sequence":"first","affiliation":[{"name":"University of Missouri College of Veterinary Medicine Department of Veterinary Medicine and Surgery, , Columbia, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Outi","sequence":"additional","affiliation":[{"name":"Centro Veterin\u00e1rio Oswaldo Cruz , S\u00e3o Jos\u00e9 dos Campos,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Rindt","sequence":"additional","affiliation":[{"name":"University of Missouri College of Veterinary Medicine Department of Veterinary Medicine and Surgery, , Columbia, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Reinero","sequence":"additional","affiliation":[{"name":"University of Missouri College of Veterinary Medicine Department of Veterinary Medicine and Surgery, , Columbia, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,1]]},"reference":[{"key":"2026020303215140200_jvim14787-bib-0001","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1748-5827.2011.01024.x","article-title":"Immunomodulatory drugs and their application to the management of canine immune-mediated disease","volume":"52","author":"Whitley","year":"2011","journal-title":"J Small Anim Pract"},{"key":"2026020303215140200_jvim14787-bib-0002","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/jvim.13642","article-title":"Predicting outcome in dogs with primary immune-mediated hemolytic anemia: Results of a multicenter case registry","volume":"29","author":"Goggs","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020303215140200_jvim14787-bib-0003","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1939-1676.2008.0060.x","article-title":"Idiopathic immune-mediated hemolytic anemia: Treatment outcome and prognostic factors in 149 dogs","volume":"22","author":"Piek","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2026020303215140200_jvim14787-bib-0004","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1748-5827.2009.00755.x","article-title":"Assessment of companion animal quality of life in veterinary practice and research","volume":"50","author":"Yeates","year":"2009","journal-title":"J Small Anim Pract"},{"key":"2026020303215140200_jvim14787-bib-0005","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1939-1676.2008.0164.x","article-title":"Concentrations of acute-phase proteins in dogs with steroid responsive meningitis-arteritis","volume":"22","author":"Bathen-Noethen","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2026020303215140200_jvim14787-bib-0006","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tvjl.2008.05.001","article-title":"The role of acute phase proteins in diagnosis and management of steroid-responsive meningitis arteritis in dogs","volume":"182","author":"Lowrie","year":"2009","journal-title":"Vet J"},{"key":"2026020303215140200_jvim14787-bib-0007","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.2460\/ajvr.1991.52.10.1738","article-title":"Haptoglobin and ceruloplasmin as determinants of inflammation in dogs","volume":"52","author":"Solter","year":"1991","journal-title":"Am J Vet Res"},{"key":"2026020303215140200_jvim14787-bib-0008","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/vco.12052","article-title":"Serum thymidine kinase 1 and C-reactive protein as biomarkers for screening clinically healthy dogs for occult disease","volume":"13","author":"Selting","year":"2015","journal-title":"Vet Comp Oncol"},{"key":"2026020303215140200_jvim14787-bib-0009","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1939-165X.2005.tb00019.x","article-title":"Acute phase proteins in dogs and cats: Current knowledge and future perspectives","volume":"34","author":"Ceron","year":"2005","journal-title":"Vet Clin Pathol"},{"key":"2026020303215140200_jvim14787-bib-0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/030098588702400115","article-title":"Prednisone-induced increases in serum alpha-2-globulin and haptoglobin concentrations in dogs","volume":"24","author":"Harvey","year":"1987","journal-title":"Vet Pathol"},{"key":"2026020303215140200_jvim14787-bib-0011","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1939-165X.2009.00146.x","article-title":"C-reactive protein concentration in dogs with primary immune-mediated hemolytic anemia","volume":"38","author":"Griebsch","year":"2009","journal-title":"Vet Clin Pathol"},{"key":"2026020303215140200_jvim14787-bib-0012","first-page":"865","article-title":"Preliminary studies of serum acute-phase protein concentrations in hematologic and neoplastic diseases of the dog","volume":"19","author":"Tecles","year":"2005","journal-title":"J Vet Intern Med"},{"key":"2026020303215140200_jvim14787-bib-0013","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1476-4431.2009.00462.x","article-title":"Use of C-reactive protein to predict outcome in dogs with systemic inflammatory response syndrome or sepsis","volume":"19","author":"Gebhardt","year":"2009","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020303215140200_jvim14787-bib-0014","first-page":"2538","article-title":"Cell cycle regulation of thymidine kinase: Residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis","volume":"11","author":"Kauffman","year":"1991","journal-title":"Mol Cell Biol"},{"key":"2026020303215140200_jvim14787-bib-0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0609.1984.tb00675.x","article-title":"Serum thymidine kinase in vitamin B12 deficiency","volume":"32","author":"Hagberg","year":"1984","journal-title":"Scand J Haematol"},{"key":"2026020303215140200_jvim14787-bib-0016","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1084\/jem.181.6.2141","article-title":"Suppression of erythro-megakaryocytopoiesis and the induction of reversible thrombocytopenia in mice transgenic for the thymidine kinase gene targeted by the platelet glycoprotein alpha IIb promoter","volume":"181","author":"Tronik-Le Roux","year":"1995","journal-title":"J Exp Med"},{"key":"2026020303215140200_jvim14787-bib-0017","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.autrev.2016.03.015","article-title":"Reduced 25-OH vitamin D in patients with autoimmune cytopenias, clinical correlations and literature review","volume":"15","author":"Fattizzo","year":"2016","journal-title":"Autoimmun Rev"},{"key":"2026020303215140200_jvim14787-bib-0018","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.coph.2010.04.001","article-title":"Vitamin D: Modulator of the immune system","volume":"10","author":"Baeke","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"2026020303215140200_jvim14787-bib-0019","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1752-1947-7-91","article-title":"Refractory immune thrombocytopenia successfully treated with high-dose vitamin D supplementation and hydroxychloroquine: Two case reports","volume":"7","author":"Bockow","year":"2013","journal-title":"J Med Case Rep"},{"key":"2026020303215140200_jvim14787-bib-0020","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1097\/MPH.0000000000000355","article-title":"Safety and efficacy of high-dose daily vitamin D3 supplementation in children and young adults with sickle cell disease","volume":"37","author":"Dougherty","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"2026020303215140200_jvim14787-bib-0021","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00109-010-0590-9","article-title":"Vitamin D and molecular actions on the immune system: Modulation of innate and autoimmunity","volume":"88","author":"Kamen","year":"2010","journal-title":"J Mol Med"},{"key":"2026020303215140200_jvim14787-bib-0022","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/vco.12101","article-title":"Serum 25-hydroxyvitamin D concentrations in dogs\u2014Correlation with health and cancer risk","volume":"14","author":"Selting","year":"2014","journal-title":"Vet Comp Oncol"},{"key":"2026020303215140200_jvim14787-bib-0023","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.theriogenology.2009.03.017","article-title":"Usefulness of C-reactive protein, serum amyloid A component, and haptoglobin determinations in bitches with pyometra for monitoring early post-ovariohysterectomy complications","volume":"72","author":"Dabrowski","year":"2009","journal-title":"Theriogenology"},{"key":"2026020303215140200_jvim14787-bib-0024","first-page":"627","article-title":"Usefulness of alpha 1 acid glycoprotein (alpha 1-AG) values in screening pound dogs acquired from animal shelters for experimental use","volume":"42","author":"Ohwada","year":"1993","journal-title":"Jikken Dobutsu"},{"key":"2026020303215140200_jvim14787-bib-0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3892\/mco.2012.19","article-title":"The proliferation marker thymidine kinase 1 in clinical use (review)","volume":"1","author":"Zhou","year":"2013","journal-title":"Mol Clin Oncol"},{"key":"2026020303215140200_jvim14787-bib-0026","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1292\/jvms.68.1275","article-title":"C-reactive protein concentration in canine idiopathic polyarthritis","volume":"68","author":"Ohno","year":"2006","journal-title":"J Vet Med Sci"},{"key":"2026020303215140200_jvim14787-bib-0027","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1292\/jvms.70.127","article-title":"C-reactive protein concentration in dogs with various diseases","volume":"70","author":"Nakamura","year":"2008","journal-title":"J Vet Med Sci"},{"key":"2026020303215140200_jvim14787-bib-0028","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ajh.10062","article-title":"Autoimmune hemolytic anemia","volume":"69","author":"Gehrs","year":"2002","journal-title":"Am J Hematol"},{"key":"2026020303215140200_jvim14787-bib-0029","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jaci.2010.03.008","article-title":"Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use","volume":"125","author":"Searing","year":"2010","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.14787","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/31\/5\/1430\/66672284\/jvim14787.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/31\/5\/1430\/66672284\/jvim14787.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:22:04Z","timestamp":1770106924000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/31\/5\/1430\/8449331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,1]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.14787","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,9]]},"published":{"date-parts":[[2017,9,1]]}}}